login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
COLLPLANT BIOTECHNOLOGIES LT (CLGN) Stock News
USA
- NASDAQ:CLGN -
IL0004960188
-
Common Stock
2.28
USD
+0.12 (+5.56%)
Last: 11/3/2025, 7:32:18 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
CLGN Latest News, Press Relases and Analysis
All
Press Releases
8 days ago - By: CollPlant
CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada
15 days ago - By: CollPlant
CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology
19 days ago - By: CollPlant
First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk
a month ago - By: Benzinga
- Mentions:
NBY
APDN
CANF
ARTL
...
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
a month ago - By: CollPlant
CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler
2 months ago - By: Benzinga
Analyst Expectations For CollPlant Biotechnologies's Future
2 months ago - By: CollPlant
CollPlant Expands the Distribution of its VergenixSTR Product in Europe
2 months ago - By: CollPlant
CollPlant to Present at the 2025 International Conference on Biofabrication
2 months ago - By: CollPlant
CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference
3 months ago - By: CollPlant
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
4 months ago - By: CollPlant
CollPlant Appoints Collagen Biomaterials Expert as New Head of North America Commercial Operations
5 months ago - By: CollPlant
COLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIES
5 months ago - By: CollPlant
COLLPLANT BIOTECHNOLOGIES ANNOUNCES EUROPEAN PATENT ALLOWANCE SECURED FOR ITS COLLAGEN-BASED FORMULATIONS USABLE AS SOFT TISSUE FILLERS AND IMPLANTS
5 months ago - By: CollPlant
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $3.6 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES
5 months ago - By: CollPlant
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE
6 months ago - By: CollPlant
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FIRST QUARTER FINANCIAL RESULTS
8 months ago - By: CollPlant
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
8 months ago - By: CollPlant
CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia
a year ago - By: CollPlant
- Mentions:
SSYS
COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
a year ago - By: CollPlant
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
Please enable JavaScript to continue using this application.